These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA. Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232 [TBL] [Abstract][Full Text] [Related]
4. pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function. Philipp J; Dabkowska A; Reiser A; Frank K; Krzysztoń R; Brummer C; Nickel B; Blanchet CE; Sudarsan A; Ibrahim M; Johansson S; Skantze P; Skantze U; Östman S; Johansson M; Henderson N; Elvevold K; Smedsrød B; Schwierz N; Lindfors L; Rädler JO Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2310491120. PubMed ID: 38055742 [TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo. Lee JB; Zhang K; Tam YY; Tam YK; Belliveau NM; Sung VY; Lin PJ; LeBlanc E; Ciufolini MA; Rennie PS; Cullis PR Int J Cancer; 2012 Sep; 131(5):E781-90. PubMed ID: 22095615 [TBL] [Abstract][Full Text] [Related]
6. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids. Park S; Choi YK; Kim S; Lee J; Im W J Chem Inf Model; 2021 Oct; 61(10):5192-5202. PubMed ID: 34546048 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach. Terada T; Kulkarni JA; Huynh A; Chen S; van der Meel R; Tam YYC; Cullis PR Langmuir; 2021 Jan; 37(3):1120-1128. PubMed ID: 33439022 [TBL] [Abstract][Full Text] [Related]
8. Acidic pH-induced changes in lipid nanoparticle membrane packing. Koitabashi K; Nagumo H; Nakao M; Machida T; Yoshida K; Sakai-Kato K Biochim Biophys Acta Biomembr; 2021 Aug; 1863(8):183627. PubMed ID: 33901441 [TBL] [Abstract][Full Text] [Related]
9. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids. Park S; Choi YK; Kim S; Lee J; Im W bioRxiv; 2021 Jun; ():. PubMed ID: 34189527 [TBL] [Abstract][Full Text] [Related]
10. Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid. Suzuki Y; Ishihara H Int J Pharm; 2016 Aug; 510(1):350-8. PubMed ID: 27374199 [TBL] [Abstract][Full Text] [Related]
11. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo. Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950 [TBL] [Abstract][Full Text] [Related]
14. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery. Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806 [TBL] [Abstract][Full Text] [Related]
15. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424 [TBL] [Abstract][Full Text] [Related]
16. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics. Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715 [TBL] [Abstract][Full Text] [Related]
17. Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery. Hirai Y; Saeki R; Song F; Koide H; Fukata N; Tomita K; Maeda N; Oku N; Asai T Int J Pharm; 2020 Jul; 585():119479. PubMed ID: 32473372 [TBL] [Abstract][Full Text] [Related]
18. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging. M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519 [TBL] [Abstract][Full Text] [Related]
19. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells. Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083 [TBL] [Abstract][Full Text] [Related]
20. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo. Biscans A; Ly S; McHugh N; Cooper DA; Khvorova A J Control Release; 2022 Sep; 349():831-843. PubMed ID: 35917865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]